Guangdong Blue Treasure Pharmaceuticals Co., Ltd.

Guangdong Blue Treasure Pharmaceuticals Co., Ltd.
科技创新

The company was created.

以人为本

Employees

Blue Treasure was founded in 1994 as a joint venture pharmaceutical company focusing on developing and manufacturing advanced specialty active pharmaceutical ingredients (APIs) and intermediates. The ownership is shared between Livzon New North River Pharmaceutical Co. Ltd., Livzon Pharmaceutical Group Inc., China State Institute of Pharmaceutical Industry, Blue Treasure Holdings Inc. of Canada, and Biotecs Far East Limited.

The company won the awards including “National High-tech Enterprise”, “National Intellectual Property Advantage Enterprise”, “Specialized, Refined, Special and New Enterprise in Guangdong Province”, “Pilot Enterprise in the Qingyuan Municipal Support Program Assisting Enterprises to Achieve Excellence”, “Enterprise of Observing Contract and Valuing Credit” for 27 consecutive years, and A-level Taxpayers in the tax credit rating system for years.

The company has a competitive and robust compensation system for attracting and keeping a quality team. Aiming to achieve professional development goals, an appropriate talent management mechanism is built to train, attract, and deploy talent to the highest-value opportunities within the company. The team consists of the talents proficient in pharmaceutical, biotechnology and biological pharmaceutical. With the leadership of management team, a professional and stable technical team has been established to achieve high-quality and sustainable development of the company.

Having extensive experience for nearly 30 years in microbiological fermentation, Blue Treasure has successively brought in Lovastatin, Mevastatin/Compactin, Pravastatin Sodium, and Mycophenolic Acid. The productivity has even been ranked one of the topmost in China and hits the highest level in the world. The leading product Pravastatin Sodium manufactured by Blue Treasure was awarded “20th China Patent Excellence Award”. The products are competitive at the aspects of advanced technology, quality and costs in globe and are distributed to the US, Canada, EU, Australia and Asia.

Guided by the notion of “To Provide the High-Quality Products with the Sincerest Services”, Blue Treasure is committed to providing comprehensive, prompt & high-quality services to our customers with the high-quality specialty APIs and intermediates. The company has been proactively participating in global competition. For the leading product Pravastatin Sodium, the facility has been inspected and approved by the domestic and international regulatory agents, such as NMPA (China), U.S. FDA, TGA and PMDA.

The company upholds innovation-driven development and makes great achievements. The company have closer enterprise-led collaboration between universities, and research institutes such as East China University of Science and Technology and has built a Guangdong Provincial Microbial Pharmaceutical Engineering Technology Research Center. The expenditure in research and development (R&D) accounts for over 5% of the sales revenues of the company. Great importance has been attached to intellectual property protection.19 patent applications were submitted and 14 patent grants were obtained. 1 trademark was obtained. The company has passed the intellectual property management system certification and was accredited as a Key Enterprise with Intellectual Property Protection in Qingyuan and a National Intellectual Property Advantage Enterprise.

Milestones

2023

Milestones
The company passed China's GMP compliance inspection at Shijiao Site for Pravastatin Sodium and filed the product with China's regulatory agency.

2022

Milestones
Shijiao Site passed the completion acceptance, and was successfully put into production.

2020

Milestones
For Pravastatin Sodilum,the facililty was inspected and approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for the first time.

2013

Milestones
Registration certificate was issued for import of Pravastatin Sodium into India.

2009

Milestones
The facility was inspected and approved by US FDA foor Pravastatin Sodium for the first time.CEP was granted.

2008

Milestones
The company passed GMP inspection by Australia TGA for the first time.

2008

Milestones
Mycophenolic Acid was put into production.

2006

Milestones
Accomplishment of the Pravastatin Technical Reconstruction Project.

2003

Milestones
The company passed China's GMP certification for Lovastatin for the first time.

2000

Milestones
Pravastatin sodium was successfully put into production and included into the 100 Science and Technology Innovation Projects of Guangdong Province.

1999

Milestones
Compactin (also called Mevastatin) was put into production in the company.

1998

Milestones
Blue Treasure for the first time and continuously was recognized as a High-Tech Enterprise.

1998

Milestones
Lovastatin passed the acceptance inspection and certification for the National-level Torch Project.

1996

Milestones
Lovastatin has been included in the national torch program and a key new product in Guangdong Province.

1996

Milestones
New Drug Certificate and Manufacturing License were granted for Lovastatin.

1994

Milestones
Blue Treasure was created.

Certificate of Honor

Enterprise of Observing Contract and Valuing Credit of Guangdong Province

Enterprise of Observing Contract and Valuing Credit of Guangdong Province

National Intellectual Property Advantage Enterprise

National Intellectual Property Advantage Enterprise

Hero Award for Average Output Value per Acre

Hero Award for Average Output Value per Acre

Specialized, Refined, and New Enterprise

Specialized, Refined, and New Enterprise

High-Tech Enterprise

High-Tech Enterprise

Picture Name

Here is the placeholder text